SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Buch, Maya [2 ]
Combe, Bernard [3 ]
Bessette, Louis [4 ]
Song, In-Ho [5 ]
Song, Yanna [5 ]
Suboticki, Jessica [5 ]
Nash, Peter [6 ]
机构：
[1] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[2] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Manchester, Lancs, England
[3] Univ Montpellier, Montpellier, France
[4] Laval Univ, Quebec City, PQ, Canada
[5] AbbVie Inc, Chicago, IL USA
[6] Griffith Univ, Brisbane, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P106
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [41] Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs Results from a retrospective cohort study
    Floris, Alberto
    Perra, Daniela
    Cangemi, Ignazio
    Congia, Mattia
    Chessa, Elisabetta
    Angioni, Maria Maddalena
    Mangoni, Arduino Aleksander
    Erre, Gian Luca
    Mathieu, Alessandro
    Piga, Matteo
    Cauli, Alberto
    MEDICINE, 2021, 100 (17) : E25481
  • [42] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J. S.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A. A.
    Camp, H. S.
    Pangan, A. L.
    RHEUMATOLOGY, 2019, 58
  • [43] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A.
    Camp, H.
    Pangan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 67 - 68
  • [44] Effect of Upadacitinib on Pain and Morning Stiffness in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic or Biologic Disease-Modifying Anti-Rheumatic Drugs
    Wells, Alvin E.
    Lee, Yvonne C.
    Tundia, Namita
    Suboticki, Jessica
    Chen, Kun
    Friedman, Alan
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] COST-EFFICACY ANALYSIS OF BIOLOGIC DRUGS IN COMBINATION WITH DMARDS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO TRADITIONAL DMARDS IN PORTUGAL - A SIMPLIFIED APPROACH
    Cafe, A.
    Monteiro, I
    Loff, J. F.
    Encarnacao, R.
    VALUE IN HEALTH, 2012, 15 (07) : A445 - A445
  • [46] ADVERSE EVENTS RELATED TO CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rojas-Zuleta, Wilmer
    Becerra-Arias, Carolina
    Donado, Jorge
    Duque-Zapata, Natalia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S80 - S81
  • [47] Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs
    Narvaez, J.
    Diaz-Torne, C.
    Ruiz, J. M.
    Hernandez, M. V.
    Torrente-Segarra, V.
    Ros, S.
    Rodriguez de la Serna, A.
    Diaz-Lopez, C.
    Sanmarti, R.
    Nolla, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (06) : 991 - 997
  • [48] EFFICACY OF TOFACITINIB IN COMBINATION WITH METHOTREXATE COMPARED TO BIOLOGICAL DMARDS IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEW
    Reyes, J. M.
    Rodriguez, A.
    VALUE IN HEALTH, 2015, 18 (03) : A1555 - A1555
  • [49] RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS DIFFERS DEPENDING ON RHEUMATOID FACTOR LEVELS IN ANTI-CITRULLINATED POSITIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bugatti, S.
    Manzo, A.
    Zanframundo, G.
    Benaglio, F.
    Sakellariou, G.
    Montecucco, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 790 - 791
  • [50] CONSISTENCY IN TIME TO RESPONSE WITH UPADACITINIB (UPA) AS MONOTHERAPY OR COMBINATION THERAPY AND ACROSS PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS (RA)
    Rubbert-Roth, Andrea
    Combe, Bernard
    Szekanecz, Zoltan
    Hall, Stephen
    Haraoui, Boulos
    Attar, Suzan Mansour Hussein
    Ekwall, Anna-Karin H.
    Song, Yanna
    Shaw, Tim
    Nagy, Orsolya
    Xavier, Ricardo M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 29 - 29
12345